Stay updated on Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page.

Latest updates to the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page
- ChecktodayChange DetectedA site-wide NIH notice about terminology changing from “Artificial Intelligence” to “Super Intelligence” was added, and the site revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.6%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check21 days agoChange DetectedNew history entries show that study results have been posted and new results-related sections (Outcome Measures (Results)) and the Limitations and Caveats have been added, along with an updated Study Status. The previous entry 'Results Submitted' has been removed in favor of these current, results-focused updates.SummaryDifference0.5%

- Check35 days agoChange DetectedA new revision v3.7.0 was added to the study record history, and the previous revision v3.6.6 was removed from the list.SummaryDifference0.1%

- Check49 days agoChange DetectedThe history page now displays Revision: v3.6.6 instead of Revision: v3.6.5, reflecting a small software update.SummaryDifference0.1%

- Check71 days agoChange DetectedA newer revision label v3.6.5 appears in the history, replacing the previous revision v3.6.4. This indicates a page version update rather than changes to the study data or descriptions.SummaryDifference0.1%

Stay in the know with updates to Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page.